New protein injection shows promise for Alzheimer's in early trial
NCT ID NCT06489015
First seen Apr 22, 2026 · Last updated May 09, 2026 · Updated 3 times
Summary
This early study tests a lab-made human protein (rHSA) given by injection to 30 people with mild to moderate Alzheimer's. The goal is to check if it is safe and if it might help slow memory and thinking decline. Participants receive one of three doses and are followed for about 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Medical College & Affiliated Hospital Of Jiujiang University
Jiujiang, Jiangxi, 332000, China
-
Luoyang Third People's Hospital
Luoyang, Henan, 471002, China
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200000, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450000, China
-
Wuhan Union Hospital of China
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.